Literature DB >> 3014540

Deficiency of cyclic AMP-dependent protein kinases in human psoriasis.

D E Brion, F Raynaud, A Plet, P Laurent, B Leduc, W Anderson.   

Abstract

To determine possible differences in the cyclic AMP-dependent protein kinases of normal and psoriatic human fibroblasts, the levels of the regulatory subunits (RI and RII, respectively) of protein kinase I and protein kinase II were quantitated by photoaffinity labeling with 8-azido[32P]cAMP. The level of RII was significantly decreased, or was undetectable, in cytosol prepared from fibroblasts from five psoriatic subjects when compared to RII levels found with normal human fibroblasts. The level of cytosolic RI was decreased in fibroblasts from four psoriatic patients and was within the normal range for one diseased patient when compared to RI levels in normal human fibroblasts. The elution profile from a DEAE-cellulose column of protein kinase activity in the soluble fraction from two psoriatic patients also showed a decrease in type I kinase activity and the complete absence of type II kinase activity. Other results indicate that the level of RI in erythrocyte membranes from psoriatic subjects is significantly decreased when compared to that of erythrocyte membranes from eight normal subjects. A significant correlation (P less than 0.001) was observed between the severity of the cutaneous manifestation of the disease and the level of RI in psoriatic erythrocyte membranes. The changes noted in the levels of RI and RII in cell types other than those thought to be specifically involved in the proliferative epidermis disorder of the disease suggest a general protein kinase deficiency.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014540      PMCID: PMC323933          DOI: 10.1073/pnas.83.14.5272

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Imbalanced cyclic AMP-cyclic GMP levels in psoriasis.

Authors:  J J Voorhees; E A Duell
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

Review 2.  Role of cyclic nucleotides in growth control.

Authors:  I H Pastan; G S Johnson; W B Anderson
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

3.  Cyclic nucleotides in cultured cells.

Authors:  F J Chlapowski; L A Kelly; R W Butcher
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

4.  The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues.

Authors:  J D Corbin; S L Keely; C R Park
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

Review 5.  Protein kinases: aspects of their regulation and diversity.

Authors:  D A Walsh; C D Ashby
Journal:  Recent Prog Horm Res       Date:  1973

6.  Cyclic 3',5'-adenosine monophosphate-dependent protein kinase of skin. II. Levels in atopic dermatitis and psoriasis.

Authors:  P D Mier; J van den Hurk; S W Holla; E P Hollman; J E Porters; M B Weemers
Journal:  Br J Dermatol       Date:  1972-12       Impact factor: 9.302

7.  Enzyme and hemoglobin retention in human erythrocyte stroma.

Authors:  C D Mitchell; W B Mitchell; D J Hanahan
Journal:  Biochim Biophys Acta       Date:  1965-07-08

Review 8.  Psoriasis.

Authors:  G G Krueger; P R Bergstresser; N J Lowe; J J Voorhees; G D Weinstein
Journal:  J Am Acad Dermatol       Date:  1984-11       Impact factor: 11.527

9.  A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mouse lymphoma cells.

Authors:  J Hochman; P A Insel; H R Bourne; P Coffino; G M Tomkins
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

10.  Testicular protein kinases. Characterization of multiple forms and ontogeny.

Authors:  P C Lee; D Radloff; J S Schweppe; R A Jungmann
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

View more
  2 in total

1.  High chemotactic response to platelet-derived growth factor of a teratocarcinoma differentiated mesodermal cell line.

Authors:  C Liapi; F Raynaud; W B Anderson; D Evain-Brion
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

2.  β-Adrenergic Receptor Trafficking, Degradation, and Cell Surface Expression Are Altered in Dermal Fibroblasts from Hypertrophic Scars.

Authors:  Amina El Ayadi; Anesh Prasai; Ye Wang; David N Herndon; Celeste C Finnerty
Journal:  J Invest Dermatol       Date:  2018-02-22       Impact factor: 8.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.